Axsome Therapeutics, Inc. (AXSM)
163.90
-2.48
(-1.49%)
USD |
NASDAQ |
Mar 03, 15:51
Axsome Therapeutics Total Assets (Quarterly) : 689.80M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 838.03M |
| Gilead Sciences, Inc. | 59.02B |
| Vanda Pharmaceuticals, Inc. | 488.95M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Amicus Therapeutics, Inc. | 949.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 601.51M |
| Shareholders Equity (Quarterly) | 88.30M |
| Debt to Equity Ratio | 2.470 |
| Current Ratio | 1.555 |
| Net Debt Paydown Yield | -0.06% |